Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,334,000 | 11,392,000 | 7,975,000 | 4,526,000 | 12,266,000 |
| Depreciation Amortization | 2,939,000 | 2,170,000 | 1,445,000 | 734,000 | 2,774,000 |
| Income taxes - deferred | 356,000 | 644,000 | 604,000 | 960,000 | -436,000 |
| Accounts receivable | -195,000 | -555,000 | -509,000 | -451,000 | 511,000 |
| Other Working Capital | -858,000 | -2,119,000 | -2,802,000 | -2,687,000 | 1,339,000 |
| Other Operating Activity | 809,000 | 1,029,000 | 814,000 | 608,000 | 117,000 |
| Operating Cash Flow | $16,385,000 | $12,561,000 | $7,527,000 | $3,690,000 | $16,571,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,860,000 | -1,101,000 | -788,000 | -295,000 | -2,211,000 |
| Net Acquisitions | -1,269,000 | -1,269,000 | -871,000 | -772,000 | -2,470,000 |
| Purchase Of Investment | -15,788,000 | -10,679,000 | -6,695,000 | -3,246,000 | -10,040,000 |
| Sale Of Investment | 11,101,000 | 6,669,000 | 3,800,000 | 2,440,000 | 7,232,000 |
| Other Investing Activity | -38,000 | -70,000 | -21,000 | -9,000 | -109,000 |
| Investing Cash Flow | $-7,854,000 | $-6,450,000 | $-4,575,000 | $-1,882,000 | $-7,598,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,874,000 | 1,896,000 | 956,000 | 715,000 | 9,484,000 |
| Debt Issued | 1,118,000 | 1,079,000 | N/A | N/A | 9,000 |
| Debt Repayment | -32,000 | -21,000 | -12,000 | -8,000 | -219,000 |
| Common Stock Issued | 1,226,000 | 685,000 | 386,000 | 247,000 | 882,000 |
| Common Stock Repurchased | -2,797,000 | -1,512,000 | -780,000 | -383,000 | -2,130,000 |
| Dividend Paid | -5,804,000 | -4,323,000 | -2,839,000 | -1,350,000 | -5,327,000 |
| Other Financing Activity | -6,565,000 | -5,390,000 | -3,598,000 | -3,043,000 | -6,791,000 |
| Financing Cash Flow | $-4,980,000 | $-7,586,000 | $-5,887,000 | $-3,822,000 | $-4,092,000 |
| Exchange Rate Effect | -6,000 | 3,000 | -162,000 | -53,000 | 161,000 |
| Beginning Cash Position | 15,810,000 | 15,810,000 | 15,810,000 | 15,810,000 | 10,768,000 |
| End Cash Position | 19,355,000 | 14,338,000 | 12,713,000 | 13,743,000 | 15,810,000 |
| Net Cash Flow | $3,545,000 | $-1,472,000 | $-3,097,000 | $-2,067,000 | $5,042,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,385,000 | 12,561,000 | 7,527,000 | 3,690,000 | 16,571,000 |
| Capital Expenditure | -2,384,000 | -1,425,000 | -897,000 | -397,000 | -2,365,000 |
| Free Cash Flow | 14,001,000 | 11,136,000 | 6,630,000 | 3,293,000 | 14,206,000 |